Trulieve Cannabis (TRLV) EPS (Weighted Average and Diluted) (2020 - 2026)

Trulieve Cannabis (TRLV) has reported EPS (Weighted Average and Diluted) for 7 consecutive years, with $0.01 the latest figure, recorded in Q1 2026.

• In Q1 2026, EPS (Weighted Average and Diluted) rose 107.07% year-over-year to $0.01; the TTM figure through Mar 2026 stood at -$0.41 (up 52.47% YoY), while the FY2025 annual figure was -$0.61, up 25.49% from the prior year.
• EPS (Weighted Average and Diluted) came in at $0.01 for Q1 2026 at Trulieve Cannabis, up from -$0.22 in the prior quarter.
• The five-year high for EPS (Weighted Average and Diluted) was $0.01 in Q1 2026, with the low at -$2.14 in Q2 2023.
• Average EPS (Weighted Average and Diluted) over 5 years is -$0.32, with a median of -$0.17 recorded in 2025.
• Across the five-year window, EPS (Weighted Average and Diluted) sank 1677.75% in 2023 and soared 107.07% in 2026, its largest moves.
• Year by year, EPS (Weighted Average and Diluted) stood at -$0.41 in 2022, then surged by 56.83% to -$0.18 in 2023, then sank by 77.87% to -$0.31 in 2024, then climbed by 28.75% to -$0.22 in 2025, then jumped by 105.43% to $0.01 in 2026.
• According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods registered $0.01, -$0.22, and -$0.14 for Q1 2026, Q4 2025, and Q3 2025 respectively.